Tag Archives: KLXI

Top 10 Undervalued Stocks To Watch For 2019

Leave a reply

The reason why the growth stocks do so much better is that they seem to show gains in value in the hundreds of percent each decade. In contrast, it is an unusual bargain that is as much as 50 percent undervalued. The cumulative effect of this simple arithmetic should be obvious. – Philip Fisher (the Father of Growth Investing)

On Jan 05, 2018, the share price of Crispr Therapeutics (NASDAQ:CRSP), a bioscience focusing on gene-editing and CAR-T to treat serious conditions such as cancers and genetic diseases, continued its rally. The stock added another $2.90 (over 12% profits)....More>>>

Top 10 Value Stocks To Own For 2019

Leave a reply

Recro Pharma (NASDAQ:REPH) has been given a $18.00 price target by equities researchers at Oppenheimer in a research report issued on Friday. The brokerage currently has a “buy” rating on the specialty pharmaceutical company’s stock. Oppenheimer’s price target indicates a potential upside of 219.72% from the stock’s current price.

REPH has been the subject of a number of other reports. Zacks Investment Research cut Recro Pharma from a “hold” rating to a “sell” rating in a research note on Tuesday, May 15th. Piper Jaffray Companies....More>>>

stock graphs

Leave a reply

For small businesses all across the U.S., business conditions will get better this year, most noticeably in the second half, when the overall economy shifts into higher gear. The rate of improvement will vary, of course, depending on the type of small business, where its located and the customers that it serves.

See Also: Kiplinger’s Economic Outlooks

Among the fastest gainers: App developers, software firms, a variety of professional service firms in accounting, insurance, architecture, etc., and restaurants, including a growing number of franchises that serve fast food,....More>>>

Best Heal Care Stocks To Watch For 2018

Leave a reply

Yesterday, our Under the Radar Moversnewsletter suggested small cap pharmaceutical stockElectromed (NYSEMKT: ELMD) is looking like its worth shorting:

If the name Electromed rings a bell, it may be because it spent some time on our bullish watchlist. We took it off the watchlist before doing anything with it, as it was a little too bullish for its own good. Sure enough, today’s high looks like a blowoff top. The current price is back to the opening price, and today’s bar looks like a near-perfect pivot point.

We’re not going to get greedy here. A dip back to the....More>>>